CARDILE, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 2.116
NA - Nord America 1.396
AS - Asia 1.129
SA - Sud America 298
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 4.993
Nazione #
US - Stati Uniti d'America 1.358
RU - Federazione Russa 1.238
SG - Singapore 399
CN - Cina 301
BR - Brasile 252
IE - Irlanda 198
SE - Svezia 169
IT - Italia 164
VN - Vietnam 153
HK - Hong Kong 90
DE - Germania 85
FR - Francia 54
FI - Finlandia 50
GB - Regno Unito 48
BD - Bangladesh 47
IN - India 42
AT - Austria 29
PL - Polonia 27
JP - Giappone 17
UG - Uganda 17
CA - Canada 16
AR - Argentina 15
MX - Messico 13
CZ - Repubblica Ceca 11
TR - Turchia 10
ZA - Sudafrica 10
ID - Indonesia 9
IQ - Iraq 9
NL - Olanda 9
EC - Ecuador 8
AE - Emirati Arabi Uniti 6
CO - Colombia 6
ES - Italia 6
PK - Pakistan 6
UA - Ucraina 6
BE - Belgio 5
EG - Egitto 5
CH - Svizzera 4
IR - Iran 4
LB - Libano 4
PS - Palestinian Territory 4
VE - Venezuela 4
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
CL - Cile 3
IL - Israele 3
PE - Perù 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
DZ - Algeria 2
EU - Europa 2
GA - Gabon 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GY - Guiana 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SI - Slovenia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 4.993
Città #
Moscow 344
Singapore 234
Chandler 196
Dublin 196
Ashburn 190
San Jose 134
Dallas 132
Beijing 113
Nyköping 110
Dong Ket 98
Hong Kong 90
The Dalles 51
Munich 46
Los Angeles 43
New York 37
Jacksonville 28
Vienna 28
Catania 27
Princeton 27
Lauterbourg 25
Medford 24
São Paulo 24
Messina 23
Warsaw 23
Buffalo 22
Cambridge 21
Des Moines 19
Houston 18
Turku 18
Kampala 17
Lancaster 17
Dearborn 14
Ho Chi Minh City 14
Hyderabad 13
Shenyang 11
Brasília 10
Jinan 10
Kameido 10
Boardman 9
Hanoi 9
Orem 9
Redondo Beach 9
Ann Arbor 8
Brno 8
Council Bluffs 8
Frankfurt am Main 8
Johannesburg 8
London 8
Santa Clara 8
Amsterdam 7
Bremen 7
Denver 7
Eboli 7
Mumbai 7
San Mateo 7
Shanghai 7
Wilmington 7
Fuzhou 6
Helsinki 6
Montreal 6
Stockholm 6
Taizhou 6
Tokyo 6
Ankara 5
Atlanta 5
Belo Horizonte 5
Brooklyn 5
Brussels 5
Chicago 5
Hebei 5
Manchester 5
Mexico City 5
Milan 5
Pune 5
Rome 5
Shenzhen 5
Tianjin 5
Augusta 4
Baghdad 4
Caxias do Sul 4
Curitiba 4
Guangzhou 4
Haikou 4
Nanjing 4
Nuremberg 4
Pelotas 4
Phoenix 4
Poplar 4
Porto Alegre 4
Taiyuan 4
Tübingen 4
Waverly Hall 4
Baku 3
Campinas 3
Changsha 3
Chennai 3
Las Vegas 3
Mislata 3
Mossoró 3
New Delhi 3
Totale 2.795
Nome #
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 240
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 234
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 222
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 201
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 183
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 183
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 173
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 165
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 148
Increased 177Lu-DOTATATE Uptake in Paget Disease 148
Meningocele mimicking a metastasis of papillary thyroid carcinoma 145
Long term follow-up of renal function in patients who underwent repeated peptide receptor radionuclide therapy 140
Paget disease revealed by Lu-177-DOTATATE post-therapy whole-body scan. 139
Demonstration of unknown primitive neuroendocrine tumor by post-treatment imaging with high activities of radiolabeled somatostatin analogues 134
Repeated administrations of peptide receptor radionuclide therapy: long term follow-up of renal function. 130
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 130
Calibration of a gamma camera for 177Lu quantitative imaging: measurements of sensitivity and scatter correction factors in broad beam geometry 128
Cognitive Effects of Transcranial Direct Current Stimulation Plus Robotic Verticalization in Minimally Conscious State 126
Exploring Consciousness Levels through Electrodermal Responses: A Pilot Study with Auditory Stimuli in DoC Patients 123
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1 120
Peptide receptor radionuclide therapy in patients with pulmonary neuroendocrine tumors: our experience 119
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 118
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature 115
Post-therapy whole-body scan in patients who underwent peptide receptor radionuclide therapy using 111In-Pentetreotide reveals more lesions than diagnostic imaging with gamma emitters 112
Differences in the sensitivity of pretherapy and post-therapy scans in patients undergoing peptide receptor radionuclide therapy 110
Usefulness of 111In-pentetreotide therapy in patients with inoperable benign intracranial tumors 109
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 107
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient 105
Gastroparesis in Adolescent Patient with Type 1 Diabetes: Severe Presentation of a Rare Pediatric Complication 96
Improving Neuroplasticity through Robotic Verticalization Training in Patients with Minimally Conscious State: A Retrospective Study 92
Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study 91
Can artificial intelligence improve the diagnosis and prognosis of disorders of consciousness? A scoping review 80
A systematic review on the use of virtual reality in post-stroke patients: exploring when modalities make the difference in executive and motor recovery 78
Recent advances (2022–2024) in eye-tracking for Parkinson’s disease: a promising tool for diagnosing and monitoring symptoms 73
Role of Nutrition in the Etiopathogenesis and Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in a Group of Obese Adults 65
What about the Use of Ice Cream as a Supplementary Diet in Chronic Kidney Disease? A Case–Control Study 65
The Impact of Social Cognition Deficits on Quality of Life in Multiple Sclerosis: A Scoping Review 64
Sex Differences in Elderly Multiple Sclerosis Patients Undergoing Neurorehabilitation: How Many Things are Taken for Granted? A Retrospective Study 61
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 60
Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients 51
Low- and high-tech AAC approaches in severe acquired brain injury: an exploratory pilot study 33
Post‑stroke disorders of ownership and agency, alien/anarchic hand syndrome: A longitudinal case analysis and systematic review 17
null 16
Case Report: Tailored automatic speech recognition in global aphasia with dysarthria - a single case proof of concept 1
Totale 5.050
Categoria #
all - tutte 15.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 0 0 102
2021/2022195 2 35 3 7 8 1 18 7 3 33 16 62
2022/2023643 56 74 27 77 51 64 10 37 224 0 16 7
2023/2024160 7 16 9 20 11 47 1 2 1 15 5 26
2024/2025733 13 5 3 50 31 37 30 114 156 68 96 130
2025/20262.868 162 122 170 169 268 568 320 388 377 158 94 72
Totale 5.050